SCHEMBL22309913

SCHEMBL22309913

CC1(C)c2ccccc2N(c2cc(-c3cccc(-c4cccc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)c4)c3)nc(-c3ccccc3)n2)c2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 4/20 0.40
▸ MAPT P10636 6/20 0.39
▸ TSHR P16473 2/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ MEN1 O00255 5/20 0.38
▸ KMT2A Q03164 5/20 0.38
▸ LMNA P02545 4/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ GLA P06280 1/20 0.38
▸ HSP90AA1 P07900 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ ADORA2A P29274 1/20 0.34
▸ ADORA1 P30542 1/20 0.34
▸ NTSR1 P30989 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ MAOB P27338 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22308926 0.88 MEN1 (0.44) HPGDMAPTTSHRMAPK1HSD17B10
SCHEMBL13231701 0.87 HTT (0.42) HPGDMAPTTSHRMAPK1HSD17B10
SCHEMBL22113750 0.86 MEN1 (0.43) HPGDMAPTTSHRMAPK1HSD17B10
SCHEMBL22308743 0.85 MEN1 (0.45) HPGDMAPTTSHRMAPK1HSD17B10
SCHEMBL22309919 0.85 MEN1 (0.45) HPGDMAPTTSHRMAPK1HSD17B10
SCHEMBL22308742 0.85 MEN1 (0.45) HPGDMAPTTSHRMAPK1HSD17B10
SCHEMBL17206568 0.83 HPGD (0.40) HPGDMAPTTSHRMAPK1HSD17B10
SCHEMBL27101449 0.83 L3MBTL1 (0.37) HPGDMAPTMEN1KMT2ALMNA
SCHEMBL22969907 0.83 ALDH1A1 (0.38) HPGDMAPTTSHRMAPK1HSD17B10
SCHEMBL13833106 0.82 MEN1 (0.36) HPGDMAPTTSHRMAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917910-B2 Organic compound and organic electroluminescent device using the same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2024-02-27 — — US disclosed
US-11917910-B2 Organic compound and organic electroluminescent device using the same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2024-02-27 — — US disclosed
US-20200251659-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOOSAN CORPORATION (KR) 2020-08-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200251659-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME VDAC1, OR10J3, PIEZO1 HPGD 3640/4885MAPT 660/4885TSHR 4541/4885
US-11917910-B2 Organic compound and organic electroluminescent device using the same VDAC1, OR10J3, PIEZO1 HPGD 3640/4885MAPT 660/4885TSHR 4541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback